ABOUT ENCLEAR

Our mission is to extend the lives of patients with CNS-related disease.

​

Our opportunity is to utilize CSF for controlled, continuous, & personalized delivery to areas of the CNS most benefited by both existing & next-generation therapeutics.

​

Our strategy is two-fold:

1) Lead with neuro-oncology and help patients with Leptomeningeal Carcinomatosis.

2) Leveraging partnerships to expand into neurodegenerative, lysosomal storage & autoimmune diseases.